You have read all your free articles, to continue reading subscribe to read the rest of this content.
Earlier this summer Immunicum announced a corporate rebranding and name change to Mendus and most recently the company reported financing commitments totaling up to 250 million SEK. NLS asked Erik Manting, CEO, about what lies ahead. What opportunities do you have on the market for cancer immunotAlready a subscriber Login…
Tromsø based ArcticZymes AS, a subsidiary of ArcticZymes Technologies, has entered into a supply and distribution agreement with precision medicine company Jiangsu Simcere Diagnostics, Nanjing, China. "This is just the beginning of a long-term relationship together where ArcticZymes' novel enzymAlready a subscriber Login You have read all your free articles,…
The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure. The licensure allows physicians in Rhode Island to order the IMMray PanCan-d test for their patients. “Receiving licensure in Rhode Island now allows us to offer Already a subscriber Login You have…
NeuroVive Pharmaceutical announced that a collaboration agreement has been signed with Karolinska Institutet regarding development of the company's compound NV556 for the treatment of mitochondrial myopathy. Under the collaboration agreement, the team led by Prof. Hakan Westerblad at Karolinska IAlready a subscriber Login You have read all your free articles,…
